1. Home
  2. MDWD vs QBTS Comparison

MDWD vs QBTS Comparison

Compare MDWD & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.84

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Logo D-Wave Quantum Inc.

QBTS

D-Wave Quantum Inc.

HOLD

Current Price

$31.78

Market Cap

9.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
QBTS
Founded
2000
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
238.5M
9.3B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MDWD
QBTS
Price
$18.84
$31.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
14
Target Price
$37.50
$31.50
AVG Volume (30 Days)
93.0K
29.4M
Earning Date
11-20-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,932,000.00
$24,144,000.00
Revenue This Year
$15.89
$194.34
Revenue Next Year
$25.33
$56.23
P/E Ratio
N/A
N/A
Revenue Growth
6.15
156.20
52 Week Low
$14.14
$3.74
52 Week High
$22.51
$46.75

Technical Indicators

Market Signals
Indicator
MDWD
QBTS
Relative Strength Index (RSI) 52.99 61.51
Support Level $18.55 $23.82
Resistance Level $19.05 $27.29
Average True Range (ATR) 0.59 2.73
MACD 0.04 0.60
Stochastic Oscillator 58.33 96.12

Price Performance

Historical Comparison
MDWD
QBTS

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

Share on Social Networks: